Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: J Allergy Clin Immunol Pract. 2021 Aug 2;9(11):4095–4102. doi: 10.1016/j.jaip.2021.07.044

Table 2.

Infections

PI3KCD n=33 PI3KR1 n=7 Combined n=40
RESPIRATORY
Recurrent Sinusitis 25 (75.8%) 2 (28.6%) 27 (67.5%)
Pneumonia 24 (72.7%) 4 (57.1%) 28 (70.0%)
Recurrent URI 20 (60.6%) 4 (57.1%) 24 (60.0%)
Otitis 20 (60.6%) 5 (71.4%) 25 (62.5%)
Dental/oral soft tissue abscesses 7 (21.2%) 0 7 (17.5%)
Thrush 3 (9.1%) 1 (14.3%) 4 (10.0%)
Tonsillitis 1 (3.0%) 0 1 (2.5%)
Ocular infections 1 (3.0%) 1 (14.3%) 2 (5.0%)
VIRAL
Herpesvirus Infection (All) 11 (33.3%) 4 (57.1%) 15 (37.5%)
EBV 7 (21.2%) 1 (14.3%) 8 (20.0%)
HSV 5 (15.2%) 2 (28.6%) 7 (17.5%)
CMV 4 (12.1%) 1 (14.3%) 5 (12.5%)
VZV 3 (9.1%) 2 (28.6%) 5 (12.5%)
Warts 3 (9.1%) 2 (28.6%) 5 (12.5%)
Molluscum 3 (9.1%) 1 (14.3%) 4 (10.0%)
HPV None 1 (14.3%) 1 (2.5%)
GASTROINTESTINAL
Chronic Diarrhea 4 (12.1%) 4 (57.1%) 8 (20.0%)
Splenic Abscess 1 (3.0%) 1 (14.3%) 2 (5.0%)
Liver Abscess 1 (3.0%) 1 (14.3%) 2 (5.0%)
OTHER
Meningitis 4 (12.1%) 0 4 (10.0%)
Skin Abscess 3 (9.1%) 1 (14.3%) 4 (10.0%)
Endocarditis 1 (3.0%) 0 1 (2.5%)

A large range of infections was exhibited, most commonly bacterial respiratory infections and herpesvirus infections. Opportunistic infections were rare, with only one PI3KCD patient who developed Pneumocystis jirovecci pneumonia. 15.0% of patients reported various abscesses